- Atlas
- Natural Sciences
- Cell Signaling
Cell Signaling
Cells live in a world of messages.
11 frameworks, from 1905 to today · Biology · Natural Sciences
- Receptor theory 1905-Present
- Neurotransmission 1921-Present
- Ion channel 1952-Present
- Second messenger system 1957-Present
- G protein-coupled receptor 1975-Present
- Receptor tyrosine kinase 1980-Present
- Small GTPase 1982-Present
- Kinase cascade signalling 1985-Present
- Nuclear receptor 1985-Present
- Spatiotemporal signalling 1995-Present
- Systems and network signalling biology 1995-Present
Overview
Cells live in a world of messages. A bacterium senses sugar and swims toward it; a neuron fires when a signal arrives at its synapse; a liver cell releases glucose when adrenaline reaches it; a dividing cell waits for permission from its neighbours. Cell signaling is the study of how cells detect, transmit, and respond to such information. What is at stake is nothing less than how a body coordinates itself: how a single fertilised egg becomes a patterned organism, how organs adjust to changing demands, and how the same molecular machinery goes wrong in cancer, diabetes, and immune disease1. The field's history is a story of moving from describing that cells respond to their environment to explaining how—through receptors, second messengers, protein switches, and networks—and then discovering that the "how" is far more intricate than any single pathway diagram suggests.
From nerve impulses to chemical transmission
The earliest strand of the field was electrical. In the late eighteenth century, Luigi Galvani showed that electricity could make frog muscles twitch, and by the nineteenth century physiologists had established that nerve signals are electrical events travelling along fibres2. The question of how a signal crosses the gap between one neuron and the next was settled in the early twentieth century. Otto Loewi's 1921 experiment—stimulating a frog heart's vagus nerve and applying the bathing fluid to a second heart, which slowed—demonstrated chemical transmission, later identified as acetylcholine. Henry Dale's work on acetylcholine and other neurotransmitters confirmed that nerves talk to their targets through chemicals. Electrical signalling and chemical signalling were thus recognised as two faces of the same communication problem.
Receptor theory: the idea of a specific receiving molecule
If chemicals carry messages, something on the target cell must receive them. The concept of the receptor emerged from pharmacology rather than biochemistry. In the early twentieth century, Paul Ehrlich proposed that drugs act on specific "side chains" of cells—his corpora non agunt nisi fixata, agents do not act unless they bind. John Newport Langley, studying nicotine and curare on muscle, argued in 1905 for "receptive substances" that combine with drugs. The decisive theoretical step came from A. J. Clark in the 1920s and 1930s, who showed that acetylcholine's effects on heart muscle followed the quantitative law of mass action, as if the drug bound reversibly to a finite number of sites. Clark's dose–response curves gave receptor theory its mathematical shape: response depends on the fraction of receptors occupied.
The theory was refined by E. J. Ariëns, who distinguished affinity (how tightly a drug binds) from intrinsic activity (how well the bound drug activates the receptor), and by R. P. Stephenson, who introduced the idea that a drug need occupy only a fraction of receptors to produce a maximal response—receptor reserve. Later work by Black and Leff formalised this as operational model. For decades the receptor remained a hypothetical entity inferred from pharmacology; its physical isolation would come later.
Second messengers: the signal goes inside
The next turning point was the discovery that a receptor's job is often to trigger a chemical cascade inside the cell. Earl Sutherland, studying how adrenaline makes liver cells release glucose, found in the late 1950s that the hormone raises levels of cyclic AMP (cAMP), a small molecule made from ATP. Sutherland proposed that the hormone binds a receptor on the cell surface, which activates an enzyme—adenylyl cyclase—that produces cAMP, which in turn activates the enzymes that mobilise glucose. cAMP was the first "second messenger": the hormone is the first messenger, cAMP the intracellular relay. Sutherland received the Nobel Prize in 197134.
The concept generalised rapidly. In the 1970s and 1980s, calcium ions were shown to be a second messenger in many contexts, and inositol trisphosphate (IP₃) and diacylglycerol (DAG) were identified by Michael Berridge, Robin Irvine, and others as products of membrane lipid breakdown that mobilise calcium and activate protein kinase C. Cyclic GMP, nitric oxide (shown by Robert Furchgott, Louis Ignarro, and Ferid Murad to relax blood vessels), and lipid messengers such as phosphatidylinositol phosphates joined the list. The second-messenger idea made signalling amplifiable: one hormone molecule can trigger many cAMP molecules, and each can activate many enzymes—a cascade with gain.
G proteins and the seven-transmembrane receptor
How does a receptor activate adenylyl cyclase? The answer came from Alfred Gilman and Martin Rodbell, who in the 1970s and 1980s showed that a guanine-nucleotide-binding protein—a G protein—sits between receptor and enzyme. Rodbell had found that GTP is required for hormone action; Gilman purified the stimulatory G protein, Gs. The receptor itself was cloned in the 1980s: the β-adrenergic receptor, isolated by Robert Lefkowitz's group, turned out to span the membrane seven times. This "seven-transmembrane" architecture defines the largest receptor family in animals, the G protein-coupled receptors (GPCRs). When a ligand binds, the receptor changes shape, activates its G protein by prompting it to exchange GDP for GTP, and the G protein's subunits then act on effectors such as adenylyl cyclase or phospholipase C. Lefkowitz and Brian Kobilka received the Nobel Prize in 2012; Kobilka's later crystal structures of GPCRs showed the conformational change directly.
GPCRs matter because they are the targets of a large share of medicines—antihistamines, beta-blockers, opioids, and many others act through them. The family also includes the light receptor rhodopsin and the olfactory receptors, so the same mechanism underlies vision and smell.
Ion channels and electrical signalling
Running alongside the chemical story was the electrical one, which matured into molecular detail. Alan Hodgkin and Andrew Huxley, working on the squid giant axon in the early 1950s, measured the currents underlying the nerve impulse and proposed that voltage-gated sodium and potassium channels open and close in a voltage-dependent way, producing the action potential. Their quantitative model predicted the shape of the impulse from channel kinetics. The channels themselves were isolated much later: Shaker, the first potassium channel gene, was cloned in the 1980s, and the first ion channel structures were solved in the 1990s and 2000s (Roderick MacKinnon's potassium channel structure in 1998 earned a Nobel Prize in 2003). Ion channels are signalling devices in their own right: they convert chemical or electrical stimuli into ion fluxes, and they underlie synaptic transmission, heartbeat, and sensory transduction. The discovery of channel-linked receptors—such as the nicotinic acetylcholine receptor, a ligand-gated ion channel—connected the chemical and electrical worlds.
Receptor tyrosine kinases and the growth-factor revolution
A different receptor class emerged from cancer research. In the late 1970s and early 1980s, Stanley Cohen and Rita Levi-Montalcini's nerve growth factor and epidermal growth factor (EGF) were shown to act through receptors that are themselves enzymes. The EGF receptor, cloned in the mid-1980s, turned out to have an intracellular kinase domain that phosphorylates tyrosine residues—on itself and on other proteins. This was a new signalling logic: the receptor is a kinase, and ligand binding activates it. The insulin receptor, cloned shortly after, proved to be a tyrosine kinase too, linking this mechanism to metabolism. The discovery that several oncogenes are mutated or overactive versions of receptor tyrosine kinases (and of downstream signalling proteins) tied the field directly to cancer. The human EGF receptor 2 (HER2) became a drug target, and trastuzumab, approved in 1998, was one of the first antibody therapies aimed at a signalling receptor.
Small GTPase switches and kinase cascades
Downstream of these receptors, cells use molecular switches. The Ras proteins, discovered as oncogenes in the early 1980s, are small GTPases: they are "on" when bound to GTP and "off" when bound to GDP, and they relay signals from receptor tyrosine kinases toward the nucleus. Ras mutations are among the most common in human cancer5. The Rho, Rab, and Arf families of small GTPases were later found to control cytoskeletal organisation, membrane traffic, and other processes. The switch logic—a protein that cycles between active and inactive states, regulated by exchange factors and GTPase-activating proteins—became a general motif.
Between receptor and response, cells also deploy kinase cascades: chains of protein kinases in which each kinase activates the next by phosphorylation. The mitogen-activated protein (MAP) kinase cascade, worked out in the 1980s and 1990s, carries signals from Ras to transcription factors; the PI3K–Akt pathway, another major cascade, controls survival and growth. Cascades provide amplification and multiple points of regulation, and their components became prime drug targets (for example, the BRAF inhibitor vemurafenib for melanoma).
Nuclear receptors: signals that enter the cell
Not all receptors sit on the surface. Steroid hormones—oestrogen, testosterone, cortisol—are lipid-soluble and cross the membrane, binding intracellular receptors that act directly as transcription factors. The oestrogen receptor was cloned in 1986, revealing a DNA-binding domain and a hormone-binding domain; the glucocorticoid receptor followed. These nuclear receptors, when bound by hormone, enter the nucleus and switch genes on or off16. The discovery that nuclear receptors are a large family of ligand-regulated transcription factors unified endocrinology with gene regulation, and the receptors became targets for drugs in cancer and metabolic disease (tamoxifen for breast cancer acts through the oestrogen receptor).
Networks, dynamics, and the systems view
By the 1990s, the pathway diagrams had become crowded, and a new question arose: how do these pathways behave as a system? Two developments pushed the field. First, genomics and proteomics made it possible to measure many components at once, and systems biology—using mathematical models and network analysis—began to treat signalling as a dynamic network rather than a set of linear routes. Second, live-cell imaging revealed that signalling is not uniform in space and time. Fluorescent reporters showed that calcium signals oscillate, that Ras activation is transient and localised, and that signalling molecules cluster in microdomains. The field of spatiotemporal signalling grew: the same molecule can produce different outcomes depending on where and when it is active. Scaffold proteins, which hold kinases together in complexes, help explain specificity—why similar cascades produce distinct responses.
The network view also brought feedback and crosstalk to the fore. Pathways that looked separate turned out to regulate each other, and the same kinase could be activated by many inputs. This complexity is now studied with computational models, single-cell measurements, and optogenetic tools that let researchers switch signalling on and off with light.
Where the field stands
Today cell signalling is a sprawling, mature field with several active fronts. Structural biology has resolved many receptors and kinases at atomic detail, guiding drug design. Single-cell and live-imaging methods show that signalling is noisy and heterogeneous even among genetically identical cells. The recognition that many diseases—cancers, immune disorders, metabolic syndromes—are signalling diseases has made the field central to medicine1. Open questions remain: how cells decode the timing and location of signals into specific responses; how signalling networks maintain robustness despite noise; how signals are integrated across scales from molecules to tissues; and how to predict the effect of a drug on a network rather than on a single target. The history of cell signalling is, in a sense, the history of biology learning that communication is not a simple wire but a living, adaptable system.
References
- Cell signaling (introduction, Intracellular receptors), Wikipedia
- Action potential (History), Wikipedia
- Signal transduction (History), Wikipedia
- Cyclic adenosine monophosphate (History), Wikipedia
- Ras GTPase, Wikipedia
- Nuclear receptor, Wikipedia
The frameworks of Cell Signaling
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1905-Present
- 1921-Present
- 1952-Present
Ion channel
How do ions move across membranes to produce electrical signals?
- 1957-Present
Second messenger system
How does a surface signal become a chemical change inside the cell?
- 1975-Present
G protein-coupled receptor
How does a seven-transmembrane receptor activate an intracellular protein?
- 1980-Present
Receptor tyrosine kinase
How do growth factors trigger enzyme activity inside the cell?
- 1982-Present
- 1985-Present
Kinase cascade signalling
How do chains of kinases relay and amplify a signal?
- 1985-Present
Nuclear receptor
How do lipid-soluble signals act directly on gene transcription?
- 1995-Present
Spatiotemporal signalling
Where and when inside the cell does a signal act?
- 1995-Present
Systems and network signalling biology
How do signalling pathways combine into networks with feedback?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Second messenger system influenced by Receptor theory
Sutherland's second-messenger model was built on the receptor concept: he proposed that adrenaline binds a surface receptor which then activates adenylyl cyclase. The receptor remained the receiving element that made the intracellular relay necessary.
Carried by Earl Sutherland.
G protein-coupled receptor grew out of Receptor theory
GPCR biology grew directly out of receptor theory and second-messenger work: the beta-adrenergic receptor was the pharmacological receptor whose cloning revealed the seven-transmembrane structure. Rodbell and Gilman's G protein work explained how such receptors act.
Carried by Martin Rodbell; Alfred Gilman; Robert Lefkowitz.
G protein-coupled receptor influenced by Second messenger system
The question of how a receptor activates adenylyl cyclase came straight from the second-messenger framework. Rodbell and Gilman answered it by finding the GTP-binding protein between receptor and enzyme.
Carried by Martin Rodbell; Alfred Gilman.
Small GTPase influenced by Receptor tyrosine kinase
Ras was placed downstream of receptor tyrosine kinases: the small GTPase switch was understood as relaying signals from activated growth-factor receptors toward the nucleus. This connected the oncogene Ras to the RTK signalling pathway.
Kinase cascade signalling influenced by Small GTPase
The MAP kinase cascade was worked out as the route from Ras to transcription: Ras activates a kinase chain that carries the signal onward. The small GTPase switch and the kinase cascade became one pathway.
Systems and network signalling biology influenced by Kinase cascade signalling
Systems and network signalling biology took the kinase cascade as its model object: the MAP kinase pathway was mapped, modelled, and analysed as a network with feedback and crosstalk. Quantitative pathway diagrams became the basis for network-level analysis.
Receptor tyrosine kinase influenced by Receptor theory
Growth-factor receptors were conceived as receptors in the pharmacological sense, but with the kinase inside: ligand binding to a specific surface receptor activates an intrinsic enzymatic domain. The EGF receptor cloning joined receptor theory to oncogene research.
Carried by Stanley Cohen.
Spatiotemporal signalling influenced by Second messenger system
Spatiotemporal signalling grew from the second-messenger framework by asking where and when cAMP, calcium, and lipid messengers act inside the cell. Imaging of local calcium and cAMP transients turned the second-messenger idea into a question of location and timing.
Spatiotemporal signalling influenced by G protein-coupled receptor
GPCR signalling provided the concrete case for spatiotemporal control: receptors, G proteins, and effectors were found to be organised in local microdomains rather than acting in a well-mixed cytoplasm. The study of receptor desensitisation and scaffolding carried this forward.
Kinase cascade signalling influenced by Receptor tyrosine kinase
Receptor tyrosine kinases activate kinase cascades: ligand binding and autophosphorylation recruit downstream kinases that phosphorylate one another in sequence. The RTK provided the upstream trigger for the MAP kinase chain.
Systems and network signalling biology influenced by Spatiotemporal signalling
Spatiotemporal data on where signalling components act fed into network models that had to account for localisation and compartmentalisation. The two frameworks developed together as quantitative, spatially resolved descriptions of signalling.
Spatiotemporal signalling influenced by Ion channel
Ion channel localisation and clustering, such as channels anchored at synapses, provided early evidence that signalling components are spatially organised. This fed the broader spatiotemporal signalling framework.
Beyond the field
Where Cell Signaling's ideas came from in other fields, and what they led to there: the strongest 12 of 63 links.
Receptor theory influenced Receptor occupancy theory in Pharmacodynamics
Receptor theory, as formulated by Ehrlich and Langley, supplied the concept of a specific receptive substance that occupancy theory then quantified with mass-action equations.
Carried by Paul Ehrlich; John Newport Langley.
Receptor theory influenced Second messenger system in Receptor Theory And Signal Transduction
The second messenger concept extended receptor theory: Sutherland showed that hormone binding to a receptor generates an intracellular messenger, inserting a step between receptor occupancy and response.
Carried by Earl Wilbur Sutherland Jr..
Receptor theory influenced Cell Signaling in Cell Biology
Receptor theory, from Ehrlich and Langley through Clark's quantitative drug-receptor work, provided the concept of a specific cellular receptor that cell signaling adopted and extended to hormone and growth factor receptors.
Carried by Paul Ehrlich; John Newport Langley; Alfred Joseph Clark.
Receptor theory led to Schild equation in Receptor Theory And Signal Transduction
Schild's analysis applied receptor theory to antagonism, expressing the competition between agonist and antagonist for the same receptor site in a quantitative equation.
Carried by Heinz Otto Schild.
Neurotransmission influenced Neurotransmitter-System Pharmacology in Neuroscience
Neurotransmission as a signaling process is the substrate this pharmacology manipulates; drugs were grouped by the transmitter pathway they modify.
Neurotransmission influenced Cell Signaling in Cell Biology
Neurotransmission research, from Loewi and Dale onward, established chemical signaling between cells and supplied the receptor and second messenger concepts that cell signaling generalized to all cells.
Carried by Otto Loewi; Henry Dale.
Ion channel grew out of Cellular and membrane physiology in Physiology
Ion channel theory is a direct outgrowth of cellular and membrane physiology, with the Hodgkin-Huxley analysis of membrane permeability as its founding achievement.
Carried by Alan Hodgkin; Andrew Huxley.
Ion channel influenced Patch clamp in Molecular Neuroscience
The patch clamp was devised to test the ion channel concept, which had been inferred from Hodgkin and Huxley's voltage-clamp work on the squid axon. Single-channel records gave the first direct demonstration that channels are discrete molecular pores.
Carried by Erwin Neher; Bert Sakmann; Alan Hodgkin.
Second messenger system led to G-Protein Transduction Model in Receptor Theory And Signal Transduction
The G-protein transduction model grew out of the second messenger system: Rodbell and Gilman showed that GTP-binding proteins couple receptors to the adenylate cyclase that generates cAMP.
Carried by Martin Rodbell; Alfred G. Gilman.
G protein-coupled receptor influenced by Second messenger system in Receptor Theory And Signal Transduction
The second messenger system, especially cAMP, provided the output that GPCR research explained: Rodbell and Gilman showed receptors couple through G proteins to adenylate cyclase.
Carried by Martin Rodbell; Alfred Gilman.
G protein-coupled receptor influenced by Second messenger system in Molecular Neuroscience
Second messenger research on cAMP cascades supplied the framework within which G protein-coupled receptors were discovered and understood.
Carried by Martin Rodbell; Alfred Gilman.
Small GTPase grew out of Tumor Suppressor Genetics in Pediatric Hematology And Oncology
Tumor suppressor and oncogene genetics identified RAS as a human oncogene in bladder carcinoma and placed it in the cancer gene framework. Small GTPase biology grew directly out of that oncogene work, with Ras mutations driving the field.
Carried by Robert Weinberg; Mariano Barbacid; Michael Wigler.

Cell Signaling is a planet in Nousfarer
Its city has a tower for each of these 11 frameworks. Land, walk in, and climb one concept at a time.
Land on Cell SignalingRelated fields
Fields its ideas are linked to
- Receptor Theory And Signal Transduction 16 links
- Molecular Neuroscience 7 links
- Endocrinology And Diabetes 6 links
- Pharmacology 6 links
- Cell Biology 5 links
- Molecular Biology 2 links
- Physiology 2 links
- Neuroscience 2 links
- Pharmacodynamics 2 links
- Systems Biology 1 link
- Medicinal Chemistry 1 link
- Environmental Toxicology 1 link